Meningococcal meningitis is a rare but potentially devastating disease which can strike anyone, anywhere in the world. 1
Fortunately, most cases can be prevented through vaccination. 1,3
At Sanofi Pasteur, we believe in a world where no one should suffer or die from this vaccine preventable disease. 1,2
Daniel Yoshizawa, paralympic athlete and meningitis survivor advocates for prevention
The fight against meningococcal meningitis is in our hands
Sanofi Pasteur’s legacy
For over 45 years, Sanofi has been at the forefront of combating meningococcal epidemics and in driving meningococcal vaccine evolution
Vaccination recommendations vary from country to country. Learn more
Parents: How to help protect your loved ones
Adolescents: Don’t let meningococcal meningitis get in your way
References
- WHO. Meningococcal meningitis. Available at: https://www.who.int/news-room/fact-sheets/detail/meningococcal-meningitis Accessed February 2021.
- ECDC. Factsheet about meningococcal disease. Available at: https://www.ecdc.europa.eu/en/meningococcal-disease/factsheet Accessed February 2021.
- Meningitis Research Foundation. What are meningitis and septicaemia. Available at: https://www.meningitis.org/meningitis/what-is-meningitis Accessed February 2021.
- Sanofi Pasteur (2020). Meningococcal Disease in Europe: A Rare but Devastating Disease.